LAXAMALT, oral powder jar, 300 g
Active ingredients: Mineral oil
Commercialized according to BDPM
Powderjar, 300 gorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- LAXAMALT, poudre orale
- Pharmaceutical form
- poudre
- Route of administration
- orale
- Presentation description
- 1 pot(s) composite polyéthylène haute densité (PEHD) polytéréphtalate (PET) métallisé papier de 300 g
- Marketing authorisation holder
- DÔMES PHARMA
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 29 Nov 2022
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66514397CIP73058856CIP133400930588567Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| PARAFFINE LIQUIDEpoudre | 50 g · 100 g de poudre orale | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.